The Valley Desk

NCT04168385 · Interventional trial

MRX-800: A Long-Term Safety Study of Maralixibat in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study

Overall registry status Completed

Phase 2

Conditions Cholestatic Liver Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov